文献速递腹部技术与安全USCTMR

术后肝脏:在CEUS LI-RADS框架内应用治疗反应评估是否可行

The post-surgical liver: is application of treatment response assessment within the CEUS LI-RADS framework possible?
PubMed 文献 · Abdom Radiol (NY) · 2025-06-04

本研究回顾性分析102例HCC和ICC手术切除后患者共120个切除部位的术后CEUS表现,将切除部位按EDGE、VOID、SURFACE DIVOT三种形态分类并套用CEUS LI-RADS TRA评分。结果显示CEUS可区分良性术后改变、类似肿块的切除空腔与真性复发,作者强烈推荐CEUS用于HCC和ICC切除术后的二次监测。

要点

  • 术后切除部位CEUS形态分为EDGE 59个(49%)、VOID 46个(38%)、SURFACE DIVOT 15个(13%)。
  • CEUS LI-RADS TRA评分:LR-TR VIABLE 23个(19%)、NONVIABLE 91个(76%)、EQUIVOCAL 6个(5%)。
  • 良性术后改变见于23个(19%)切除部位,CEUS可区分良性组织迁移、类似肿块的切除空腔与真性复发。

核心结论

  • CEUS能成功区分良性组织迁移、类似内在肿块的切除空腔与真性复发,作者强烈推荐CEUS用于HCC和ICC切除术后的二次监测;作者认为将切除部位纳入CEUS LI-RADS TRA算法用于消融治疗的研究非常成功。

研究设计与样本

  • 回顾性病历复习,纳入本中心102例HCC和ICC手术切除后行术后CEUS的患者,共115次手术、120个切除部位(94例HCC、8例ICC);将原肿瘤所在切除部位设为治疗部位、切除缘设为瘤周组织,以等同消融治疗TRA的方式进行评估。

关键影像表现/征象

  • 切除部位形态采用新描述词分为EDGE 59个(49%)、VOID 46个(38%)、SURFACE DIVOT 15个(13%),n=120。
  • CEUS上可见良性组织迁移、切除空腔(VOID)呈类似内在肿块的表现,以及真性复发。
  • 良性术后改变发生于23个(19%)切除部位,n=120。

诊断标准与关键数值

  • CEUS LI-RADS TRA评分结果:LR-TR VIABLE 23个(19%)、LR-TR NONVIABLE 91个(76%)、LR-TR EQUIVOCAL 6个(5%),n=120。
  • 切除部位按EDGE、VOID、SURFACE DIVOT三种形态描述,治疗部位为原肿瘤所在切除部位、瘤周组织为切除缘。

临床应用与阅片要点

  • 作者强烈推荐CEUS用于HCC和ICC切除术后的二次监测。
  • 作者认为将切除部位纳入CEUS LI-RADS TRA算法用于消融治疗的研究非常成功,提升了全体人员对CEUS评估术后肝脏重要性的认识及向转诊临床医生传达信息的方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: To appraise the inclusion of CEUS resection site evaluation in LI-RADS CEUS Nonradiation Treatment Response Assessment (TRA) v2024, currently applied for ablative therapy. We highlight the specific benefits afforded by CEUS in this effort.

METHODS: Retrospective chart review was performed for 102 patients following surgical resection of HCC and ICC with post-operative CEUS at our center. Demographic data, surgical history, CT/MR findings, and resection site appearances on greyscale and CEUS were documented. The resection site where the tumor was originally positioned was designated as the treatment site and the resection margin as the perilesional tissue to establish equal assessment to TRA for ablative therapy. The morphology of the resection site was assigned one of three appearances, using novel descriptors: EDGE, VOID, or SURFACE DIVOT. Resection sites were evaluated for benign appearances, post-surgical changes, and tumor recurrence, and then categorized with a CEUS LI-RADS TRA score.

RESULTS: 102 patients had 120 resection sites following 115 operations for 94 HCC and 8 ICC. On CEUS, 59 (49%) were characterized as EDGE, 46 (38%) as VOID, and 15 (13%) as SURFACE DIVOT, n = 120. 23 (19%) of resection sites were LR-TR VIABLE for recurrence, 91 (76%) LR-TR NONVIABLE, and 6 (5%) EQUIVOCAL, n = 120. Benign post-surgical changes developed in 23 (19%) resection sites, n = 120. 63/115 surgeries (55%) had post-operative recurrence, 40 De Novo, 17 Perilesional, and 6 Intralesional.

CONCLUSION: Our conclusions are in two categories: the first assessing the success of CEUS in the assessment of post-surgical treatment sites following liver resections. CEUS can successfully distinguish between unique post-operative appearances such as benign tissue migration, resection VOIDs resembling an intrinsic mass, and true recurrence. CEUS is thus strongly recommended for secondary surveillance following HCC and ICC resection. The second conclusion evaluates the inclusion of resection sites into the CEUS LI-RADS TRA algorithm for ablative therapies. In this regard, we believe that our study was highly successful, improving the perspective of all our staff as to what is important in the assessment of the post-surgical liver on CEUS and the method whereby this information is communicated to our referring clinicians.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Samuel AS, Qiao A, Merrill CD, et al. The post-surgical liver: is application of treatment response assessment within the CEUS LI-RADS framework possible? Abdom Radiol (NY). 2025. PMID: 40464848. doi:10.1007/s00261-025-05046-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。